| Literature DB >> 30319449 |
Liliane Appratto De Souza1, Janaina Barcellos Ferreira2, Andressa Silveira de Oliveira Schein1, Daniela Ravizzoni Dartora1, Adenauer Girardi Casali3, Catharina M Carvalho Scassola3, Eleonora Tobaldini4, Nicola Montano4, Stefano Guzzetti4, Alberto Porta5,6, Maria Claudia Irigoyen1,2, Karina Rabello Casali1,3.
Abstract
Controlled breathing maneuver is being widely applied for cardiovascular autonomic control evaluation and cardiac vagal activation through reduction of breathing rate (BR). However, this maneuver presented contradictory results depending on the protocol and the chosen BR. These variations may be related to the individual intrinsic profile baseline sympathetic tonus, as described before by others. In this study, we evaluated the effect of controlled breathing maneuver on cardiovascular autonomic control in 26 healthy subjects allocated into two protocols: (1) controlled breathing in three different rates (10, 15, and 20 breaths/min) and (2) controlled breathing in rates normalized by the individual spontaneous breathing rate (SBR) at 100, 80, 70, and 50%. Our results showed autonomic responses favorable to vagal modulation with the lower BR maneuvers. Nevertheless, while this activation was variable using the standard protocol, all participants of the normalized protocol demonstrated an increase of vagal modulation at 80% BR (HFnu 80 = 67.5% vs. 48.2%, p < 0.0001). These results suggest that controlled breathing protocols to induce vagal activation should consider the SBR, being limited to values moderately lower than the baseline.Entities:
Keywords: autonomic nervous system; controlled breathing; heart rate variability; spectral analysis; vagal stimulation
Year: 2018 PMID: 30319449 PMCID: PMC6168675 DOI: 10.3389/fphys.2018.01341
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Autonomic cardiovascular control of standard protocol group.
| HR (bpm) | 60.69± 10.92 | 60.03 ± 11.95 | 59.79 ± 11.17 | 59.43 ± 11.04 | 0.83 |
| SAP (mmHg) | 104.86 ± 16.04 | 102.57 ± 8.82 | 101.22 ± 13.4 | 104.19 ± 9.48 | 0.78 |
| SDNN (mss) | 57.46 ± 27.06 | 57.46 ± 27.03 | 52.09 ± 18.27 | 45.62 ± 15.65*# | |
| RMSSD (ms) | 54.82 ± 30.60 | 54.82 ± 30.60 | 52.08 ± 24.93 | 46.69 ± 24.30 | 0.31 |
| pNN50(ms) | 32.35 ± 24.64 | 32.35 ± 2.64 | 32.18 ± 24.36 | 24.77 ± 21.83 | 0.24 |
| HRV (ms2) | 1786.18 (1057.9–4281.95) | 2959.62 (1619.57–4794.65) | 2797.81 (1364.5–5163.25) | 1957.86 (880.13–3382.84) | 0.45 |
| LFa (ms2) | 493.16 (246.3–1473.93) | 434.51 (161.06–1004.96) | 452.55 (192.82–2266.79) | 518.67 (264.83–646.21) | 0.23 |
| LF nu | 43.44 (33.73–51.33) | 31.80 (9.87–4.21)* | 46.42 (21.98–84.65)# | 54.62 (34.18–63.49)# | |
| HFa (ms2) | 1093.92 ± 1054.26 | 1832.73 ± 1610.46* | 920.37 ± 1098.35# | 804.46 ± 773.96# | |
| HF nu | 55.71 (38.30–59.01) | 66.87 (46.10–88.53)* | 45.98 (13.62–76.12)# | 43.81 (33.81–61.05)# | |
| SAPV (mmHg2) | 13.04 (5.46–21.23) | 12.53 (6.1–46.67) | 10.25 (4.37–24.95) | 9.06 (2.45–17.31) | 0.49 |
| LFabs (mmHg2) | 1.63 ± 1.10 | 5.57 ± 6.48 | 5.52 ± 5.69 | 2.32 ± 2.72 | 0.09 |
| HFabs (mmHg2) | 0.98 (0.5–1.37) | 1.98 (1.4–3.81) | 0.63 (0.32–0.93) | 0.61 (0.46–1.05) | |
| α–index | 26.63 ± 20.99 | 14.65 ± 11.37 | 27.98 ± 25.36 | 31.20 ± 24.63 | 0.14 |
Data with normal distribution are presented as mean ± standard deviation and data with abnormal distribution are presented as median (interquartile 25% e 75%). Significant differences tested by one Way ANOVA for repeated measurements, follow by Tukey test are highlited with (.
Figure 1Standard Protocol Results (N = 10) - Spectral analysis of autonomic control applied to HRV series of SP. (A) shows the spectral power in absolute values of high frequency band (HFabs) and (B) shows the normalized values of the same component HF. Statistically significant difference compared to blocks: Basal (*) and R10 (#).
Figure 2Standard Protocol Results (N = 10) - Effect of controlled ventilation maneuvers on the normalized HF component (HFnu) in subjects treated with SP. Solid lines denote transitions with increased HF component with respect to the baseline during the maneuver controlled ventilation. The dotted lines marked decrease in this component during the maneuver. The protocol induced an increase in HFnu on (A) 8 of 10 subjects in R10, (B) 5 of 10 in R15 and (C) 4 of 10 in R20.
Figure 3Normalized Protocol Results (N = 16): Spectrum examples of Heart Rate Variability (above) and the respiratory signal (below) in spontaneous breathing rate (SBR) ventilatory control situations in the normalized frequency at (A) 100% of the SBR, (B) 70% of the SBR and (C) 50% of the SBR. The underlined area corresponds to higher spectral coherence and demonstrates the shift of the peaks toward the called LF band (0.04-0.15 Hz).
Figure 4Normalized Protocol Results (N = 16): Parameters for the assessment of autonomic control through spectral analysis applied to the pulse interval series of NP. (A) shows the normalized spectral power of the high frequency HF (HFnu) band, (B) shows the normalized spectral power of the low frequency band LF (LFnu) and (C) shows the relationship between the spectral bands LF/HF. Statistically significant difference compared to blocks: Basal (*) and 100% (#).
Figure 5Normalized Protocol Results (N = 16): Effect of controlled ventilation maneuver on the normalized HF component (HFnu) in subjects treated with NP. Solid lines denote transitions with increased HF component when compared with baseline. The dotted lines marked decrease in this component. The protocol induced an increase or no change in the HF component (A) on 13 of 16 individuals into the group 100%, (B) in all 16 subjects into the group 80%, (C) in 13 of 16 individuals into the group 70%, (D) in 8 of 16 individuals into the group 60% and (E) in 6 of 16 individuals into the group 50%. The red dots indicate the spectral overlap of the HF band on the LF, blocking the application of such methodology.
Autonomic Cardiovascular Control of Normalized Protocol Group.
| HR (bpm) | 70 ± 10 | 70 ± 11 | 69 ± 10 | 70 ± 10 | 70 ± 10 | 70 ± 9 | 0.95 |
| SAP (mmHg) | 116 ± 14 | 114 ± 14 | 118 ± 15 | 119 ± 14 | 117 ± 15 | 115 ± 16 | 0.28 |
| SDNN (mss) | 50.96 ± 21.98 | 53.89 ± 37.97 | 57.01 ± 30.91 | 58.63 ± 27.44 | 62.25 ± 31.42 | 60.46 ± 16.57 | 0.07 |
| RMSSD (ms) | 53.87 ± 39.21 | 50.98 ± 39.79 | 53.57 ± 39.18 | 51.21 ± 32.2 | 53.58 ± 35.84 | 55.58 ± 39.72 | 0.27 |
| pNN50(ms) | 23.51 ± 22.47 | 24.13 ± 25.05 | 28.45 ± 24.09 | 26.43 ± 22.1 | 26.99 ± 23.35 | 27.18 ± 20.32 | 0.34 |
| 16 | 16 | 16 | 14 | 8 | 6 | ||
| HRV (ms2) | 2301 ± 1931 | 2603 ± 2157 | 2877 ± 2008 | 3108 ± 2236 | 4076 ± 2914 | 3461 ± 1105 | 0.61 |
| VLFa (ms2) | 387.07 ± 447.81 | 311.87 ± 366.88 | 421.33 ± 471.73 | 465.91 ± 469.59 | 510.15 ± 706.83 | 547.1 ± 351.51 | 0.29 |
| LFa (ms2) | 875 ± 867 | 953 ± 1309 | 605 ± 483 | 553 ± 527 | 489 ± 285 | 427 ± 231 | 0.34 |
| LF nu | 48.5 ± 19.4 | 39.2 ± 23.3 | 28.6 ± 19.4* | 26.2 ± 17.6* | 16.8 ± 6.4*# | 16.4 ± 9.2*# | < |
| HFa (ms2) | 976 ± 998 | 1253 ± 1203 | 1759 ± 1479 | 1992 ± 1768 | 2817 ± 2109 | 2292 ± 1022 | 0.05 |
| HF nu | 48.2 ± 18.7 | 55.4 ± 20.8 | 67.5 ± 18.8* | 70.4 ± 18.1*# | 81 ± 6.4*# | 82.3 ± 8.7*# | < |
| LF/HF | 1.62 ± 1.85 | 1.25 ± 1.72 | 0.59 ± 0.67* | 0.50 ± 0.58* | 0.21 ± 0.09* | 0.21 ± 0.15 | |
| SAPV (mmHg2) | 23.2 ± 24.0 | 22.1 ± 17.3 | 26.9 ± 24.9 | 30.8 ± 30.5 | 28.3 ± 17.8 | 42.1 ± 37.0 | 0.47 |
| LFabs (mmHg2) | 5.6 ± 12.5 | 6.9 ± 9.6 | 15.4 ± 25.6 | 9.6 ± 14.9 | 12.9 ± 17.4 | 18.0 ± 21.0 | 0.32 |
| α-index | 12.6 ± 5.5 | 15.2 ± 12.0 | 14.5 ± 11.1 | 13.4 ± 11.7 | 14.6 ± 17.8 | 13.2 ± 16.7 | 0.69 |
Data are presented as mean ± standard deviation and data with abnormal distribution were analyzed through Shapiro Wilk Test. Statistic (p) from Linear Mixed Model (LMM). Significant multiple comparisons corrected by Bonferroni's method: (.